Jul. 15 at 11:39 AM
$PRCT
Procept BioRobotics Corp (NASDAQ: PRCT)
Buy (1)
ESG Score: 67/100
Price Target:
$85.00
CMS Proposed PFS Aquablation Reimbursement Lower vs Prior Assumption
THE TD COWEN INSIGHT
CMCMS proposed a 2026 Medicare physician payment of ~
$542 for Aquablation under a new Category I CPT code - below our ~
$600 estimate that we published last night. The impact of lower physician reimbursement level on Aquablation adoption and utilization will continue to be debated and the overhang may not be fully removed in the near term.